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Activation of GABAB receptors in chick dorsal root
ganglion (DRG) neurons inhibits the Cav2.2 calcium
channel in both a voltage-dependent and voltage-inde-
pendent manner. The voltage-independent inhibition
requires activation of a tyrosine kinase that phospho-
rylates the 1 subunit of the channel and thereby re-
cruits RGS12, a member of the “regulator of G protein
signaling” (RGS) proteins. Here we report that RGS12
binds to the SNARE-binding or “synprint” region (amino
acids 726–985) in loop II-III of the calcium channel 1
subunit. A recombinant protein encompassing the N-
terminal PTB domain of RGS12 binds to the synprint
region in protein overlay and surface plasmon reso-
nance binding assays; this interaction is dependent on
tyrosine phosphorylation and yet is within a sequence
that differs from the canonical NPXY motif targeted
by other PTB domains. In electrophysiological ex-
periments, microinjection of DRG neurons with syn-
print-derived peptides containing the tyrosine residue
Tyr-804 altered the rate of desensitization of neuro-
transmitter-mediated inhibition of the Cav2.2 calcium
channel, whereas peptides centered about a second
tyrosine residue, Tyr-815, were without effect. RGS12
from a DRG neuron lysate was precipitated using syn-
print peptides containing phosphorylated Tyr-804. The
high degree of conservation of Tyr-804 in the SNARE-
binding region of Cav2.1 and Cav2.2 calcium channels
suggests that this region, in addition to the binding of
SNARE proteins, is also important for determining the
time course of the modulation of calcium current via
tyrosine phosphorylation.
Multiple G protein-mediated signaling pathways are known
to modulate Cav2.2 (N-type) calcium channels (1, 2) via direct G
protein-ion channel interactions, activation of second messen-
ger cascades, and activation of tyrosine kinases (3, 4). This
modulation of voltage-dependent calcium channels is a tran-
sient phenomenon. Upon prolonged exposure to a neurotrans-
mitter, neurons become unresponsive or desensitized. Despite
the common requirement for the activation of a G protein-
coupled receptor kinase (GRK3) for desensitization of the neu-
rotransmitter-mediated inhibition of calcium current (5),
Gi- and Go-mediated pathways exhibit different rates of desen-
sitization (6) that may result from selective effects of the G-
directed GTPase-accelerating activity borne by “regulator of G
protein signaling” (RGS)1 proteins (7, 8).
In dorsal root ganglion (DRG) neurons, the activation of
-aminobutyric acid type B (GABAB) receptors induces both
voltage-dependent and voltage-independent inhibition of
Cav2.2 channels (9). Voltage-independent inhibition requires
the activation of a tyrosine kinase that phosphorylates the
pore-forming -subunit of the calcium channel (10). The ty-
rosine-phosphorylated form of the -subunit becomes a target
for the phosphotyrosine binding (PTB) domain of RGS12, a
member of the RGS protein superfamily that specifically accel-
erates the rate of desensitization of this response (10).
To better understand the molecular basis for the RGS12-
Cav2.2 channel interaction and its functional implications, we
used recombinant proteins and peptides containing the cytoplas-
mic regions of the 1 subunit of the Cav 2.2 channel to map the
site of interaction with RGS12. Results from protein-protein in-
teraction and electrophysiological experiments indicate that the
SNARE-binding region of the channel interacts with RGS12. The
SNARE-binding region of calcium channels has been shown to
bind the target SNAREs syntaxin and SNAP-25 and the vesicu-
lar SNARE synaptotagmin (11). The binding of syntaxin to the
channel is important for stabilization of the binding of G sub-
units (12). Our results suggest that a tyrosine-based motif within
the synprint region (centered about Tyr-804) plays an important
role in determining the rate of desensitization of GABA-mediated
voltage-independent inhibition.
EXPERIMENTAL PROCEDURES
Materials—Recombinant active Src and the anti-phosphotyrosine
4G10 antibody (1:2000) were obtained from Upstate Biotechnology
(Lake Placid, NY). The anti-RGS12 antiserum raised against the RGS
box has been described previously by Schiff et al. (10). The ProFound
pull-down biotinylated protein-protein interaction kit was obtained
from Pierce. A pET30 vector (Novagen) was used for the expression of
His6-tagged channel loop constructs. Chemicals were purchased from
Sigma. Anti-syntaxin (1:1000) was obtained from StressGen.
Peptides—Sequences of the peptides used in this study were based on
the Cav2.2 1 sequence from chick DRG neuron (CDB1; GenBank
TM
* This work was supported in part by National Institutes of Health
Grant NS 37443 and a Hirschl Trust Fund Career Development Award
to (to M. D.-P.). The costs of publication of this article were defrayed in
part by the payment of page charges. This article must therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
□S The on-line version of this article (available at http://www.jbc.org)
contains a table of sequences for synthetic peptides containing Tyr-804
and/or Phe-815.
¶ Supported by National Institutes of Health Grant GM062338.
 To whom correspondence should be addressed: Mount Sinai School
of Medicine, Dept. of Pharmacology and Biological Chemistry, 1
Gustave L. Levy Place, Box 1603, New York, NY 10029. Tel.: 212-241-
5569; Fax: 212-996-7214; E-mail: Maria.Diverse@mssm.edu.
1 The abbreviations used are: RGS, regulator of G protein signaling;
DRG, dorsal root ganglion; GABA, -aminobutyric acid; GST, glutathi-
one S-transferase; PTB, phosphotyrosine binding; SNARE, soluble N-
ethylmaleimide-sensitive factor attachment protein receptors; SPR,
surface plasmon resonance.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 280, No. 2, Issue of January 14, pp. 1521–1528, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 1521
This is an Open Access article under the CC BY license.
accession number AAD51815). Peptides were synthesized by FastMoc
chemistry at the Tufts University Core Facility (Boston, MA) and pu-
rified by high pressure liquid chromatography with 97% purity as
determined by mass spectrometry. An amino-terminal biotin was in-
cluded in every peptide. Peptides were first dissolved in 5 mM acetic acid
at 1 mg/ml and then diluted into the internal solution for electrophysi-
ological experiments or a HEPES-buffered saline solution for biochem-
ical experiments.
Cell Culture—Embryonic chick sensory neurons were grown in cul-
ture as described previously (5). Dorsal root ganglia were dissected from
11–12-day-old chick embryos. Cells used for electrophysiology were
plated at a density of 50,000 cells per collagen-coated 35-mm tissue
culture dish and studied for 1–3 days in vitro.
Electrophysiology—Whole-cell recordings were performed as de-
scribed (5). For extracellular application, agents were diluted into
standard extracellular saline and applied via a wide bore pipette. The
calcium current was corrected for rundown by measuring calcium cur-
rent as a function of time in control cells without a neurotransmitter.
Cells used for experiments exhibited a rundown of the current of 1%
per minute.
The external saline contained 133 mM NaCl, 1 mM CaCl2, 0.8 mM
MgCl2, 10 mM tetraethylammonium chloride, 25 mM HEPES, 12.5 mM
NaOH, 5 mM glucose, and 0.3 M tetrodotoxin. The pipette internal
solution contained 150 mM CsCl, 10 mM HEPES, 5 mM MgATP, and 5
mM bis-(o-aminophenoxy)ethane-tetraacetic acid. Pipettes resistances
prior to forming high resistance seals ranged from 1–2 megaohms.
Data Analysis—Data were filtered at 3 kHz, acquired at 10–20 kHz,
and analyzed using PulseFit (HEKA) and IgorPro (WaveMetrics) on a
Macintosh G3 computer. Strong depolarizing conditioning pulses (to 80
mV) that preceded test pulses (to 0 mV) reversed GABA-induced voltage-
dependent inhibition without affecting voltage-independent inhibition.
Such conditioning pulses had no effect on the control currents recorded
in the absence of GABA. During neurotransmitter application, test
pulse currents measured before and after the conditioning pulse were
subtracted to yield the voltage-dependent component. Test pulses meas-
ured following the conditioning pulse were subtracted from control
currents (measured in the absence of GABA) to yield the voltage-
independent component.
In Vitro Phosphorylation—In vitro phosphorylation of recombinant
channel loop proteins was performed using a recombinant active form of
Src kinase (Upstate Biotechnology). 10–20 units of recombinant Src per
assay were used. The kinase reaction buffer contained 100 mM Tris-
HCl, pH 7.2, 125 mM MgCl2, 25 mM MnCl2, 2 mM EGTA, 0.25 mM
sodium orthovanadate, 2 mM dithiothreitol, and 100 M ATP. Reactions
were incubated for 40 min at 30 °C and terminated by the addition of
Laemmli sample buffer. Proteins were resolved in a 12% SDS acrylam-
ide gel, and tyrosine phosphorylation was detected using immunoblot-
ting with the anti-phosphotyrosine antibody 4G10 (1:1000).
For phosphorylation reactions using [-32P]ATP (Amersham Bio-
sciences), 10 Ci per reaction was used. Bands containing the recom-
binant proteins were excised from the gels and quantified in the scin-
tillation counter using liquid scintillant. Reported values represent the
results of three independent assays with each sample performed in
duplicate.
Cellular Phosphorylation of the Tyr-804 Peptide—A biotinylated Tyr-
804 peptide was synthesized with an N-terminal Antennapedia pen-
etratin motif (Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-
Trp-Lys-Lys) that allows the peptide to permeate the membrane. A
stock solution of the peptide Antennapedia penetratin-Tyr-804 was
incubated alone for 15 min at 37 °C prior to its addition to the DRG
medium at a final concentration of 1.4 g/ml. DRG neurons were
treated in the presence of the peptide for 15 min in a humidified, 5%
CO2 incubator at 37 °C prior to exposure to 100 M baclofen or saline
(vehicle control) for 20 s. After agonist treatment, DRG neurons were
lysed with ice-cold buffer (phosphate-buffered saline, pH 7.4, containing
250 M sodium pervanadate, 1% (v/v) Nonidet P-40, 1 mM Pefabloc, 1
mM EDTA, 1 mM EGTA, 10 g/ml pepstatin, 10 g/ml leupeptin, 100
g/ml soybean trypsin inhibitor, and 100 g/ml calpain I and 100 g/ml
calpain II inhibitors). DRG neuron lysates (25 l) were then applied
onto a SAM2 biotin capture membrane (Promega) to capture the bioti-
nylated peptide, and tyrosine phosphorylation was detected using im-
munoblotting with the anti-phosphotyrosine antibody 4G10 (1:500;
Upstate Biotechnology).
Immunoblot Quantitation—For quantitation of bands in immunob-
lots visualized using chemiluminescence, images were obtained using a
Molecular Dynamics Personal Densitometer SI. ImageQuant 1.11 (for
Macintosh) was used to analyze the data. Values were pooled for all of
the experiments, and mean  S.E. was plotted.
All experiments were repeated 2–5 times with similar results. Rep-
resentative examples are shown for the biochemical experiments. For
electrophysiological experiments, data derived using cells from three
independent platings are shown.
Surface Plasmon Resonance (SPR) Biosensor Measurements—SPR
binding assays were performed at 25 °C on a BIAcore 3000 (BIAcore
Inc., Piscataway, NJ) at the University of North Carolina Depart-
ment of Pharmacology Protein Core Facility. For the screening of
relative binding specificity, N-terminally biotinylated, synthetic pep-
tides were bound to a streptavidin-coated sensor surface (Sensor Chip
SA, BIAcore, Uppsala Sweden) per the manufacturer’s instructions at
a density of 400 resonance units. Binding analyses were performed
using HBS-EP buffer (0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM
EDTA, and 0.005% surfactant P20) as the running buffer. The GST-
rRGS12-(1–440) fusion protein, purified as described previously (20),
was diluted in HBS-EP buffer and injected at a 10 l/min flow rate
over four flow cell surfaces simultaneously using the KINJECT com-
mand. Surface regeneration was performed by 10-l injections of
0.05% SDS in HBS-EP buffer at a 20 l/min flow rate. Background
binding to a negative control peptide surface (control) was subtracted
from all binding curves using BIAevaluation software version 3.0
(BIAcore Inc.) and plotted using GraphPad Prism version 4.0 (Graph-
Pad Software Inc., San Diego, CA).
For quantitative binding analyses of the phosphotyrosine synprint
motif, N-terminally biotinylated Tyr(P)-804/Tyr-815 peptide (biotin-
Met-His-Asn-Phe-Arg-Asn-Ser-Cys-Glu-Ala-Leu-Tyr(P)-Asn-Glu-Leu-
Asp-Pro-Glu-Glu-Arg-Val-Arg-Tyr-Ala-Thr-Thr-Leu) was bound to a
streptavidin-coated sensor surface to a density of 0, 100, and 400
resonance units, respectively, on three independent flow cell surfaces.
To eliminate any potential contribution of GST/GST dimerization to
kinetic binding measurements, the open reading frame of the pGEX-
RGS12-(1–440) construct was recloned by PCR into the hexahistidine-
tagged prokaryotic expression vector pProEXHTb (Invitrogen), and the
recombinant His6-RGS12-(1–440) protein was purified from Esche-
richia coli by sequential application of a Ni2-nitrilotriacetic acid affin-
ity matrix, anion exchange, and size exclusion chromatographic sepa-
rations using previously described methods (13). Kinetic analyses of
His6-rRGS12-(1–440) binding to the Tyr(P)-804/Tyr-815 peptide were
performed using a running buffer containing 0.05 M Tris-HCl, pH 7.5,
0.15 M NaCl, 1 mM dithiothreitol, and 5% (v/v) glycerol. Purified His6-
rRGS12-(1–440) protein was diluted in running buffer at concentra-
tions ranging from 1 to 20 M, and 50 l of it was injected at a flow rate
of 20 l/min over four flow cell surfaces simultaneously using the
KINJECT command. The sensorgrams were normalized to the signal
achieved due to binding the control “blank” flow cell surface (0 reso-
nance units), and the normalized data were globally fit to a 1:1 binding
model (bulk refractive index effect  0) using BIAevaluation software
version 3.0. The resultant apparent dissociation constant (KD) was
derived from calculated kon and koff rates and is the result of four
independent sets of titrations.
Binding of Endogenous RGS12 to Channel Peptides—Affinity col-
umns were prepared by incubating 100 g of N-terminally biotinylated
synthetic peptides with streptavidin-Sepharose beads per the manufac-
turer’s instructions (Pierce). 2 mg of DRG lysate was loaded onto the
biotinylated peptide-avidin column and incubated for 4 h at 4 °C. Neg-
ative controls using beads without peptide and a lysate from HEK293T
cells were run in parallel. Elution was performed per the manufactur-
er’s instructions (Pierce). Eluate was mixed with Laemmli sample
buffer and resolved by electrophoresis on a 7.5% SDS-polyacrylamide
gel. Immunodetection of RGS12 was carried out as described previously
using an antibody raised against the RGS box (1:1000) (10); syntaxin
was detected using anti-syntaxin (1:1000, Stressgen)
RESULTS
RGS12 Binds to the Tyrosine-phosphorylated Synprint Re-
gion of Cav2.2 Channel—The PTB domain of RGS12 (amino
acids 236–440) binds to the tyrosine-phosphorylated form of
the Cav2.2 channel in a neurotransmitter-induced manner, and
this interaction accelerates the desensitization of neurotrans-
mitter-mediated channel inhibition (10). We have previously
reported that the SNARE-binding (or synprint) region and the
C terminus of the 1 subunit of the Cav2.2 channel can be
phosphorylated by Src kinase (14). To determine which region
of the 1 channel subunit binds to RGS12, we performed over-
lay assays using recombinant proteins encompassing cytoplas-
mic regions of the Cav2.2 1 subunit. In these overlay assays, a
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recombinant GST fusion protein comprising the first 440 amino
acids of rat RGS12 bound to an in vitro Src-phosphorylated
channel loop encompassing the synprint region (Fig. 1A). This
binding was dependent on phosphorylation, as no binding was
seen without prior Src phosphorylation (data not shown). De-
spite the fact that the C terminus is heavily phosphorylated
(14), no binding to GST-RGS12 was detected for this region of
the channel.
The synprint region of the chick Cav2.2 1 subunit contains
two tyrosine residues, Tyr-804 and Tyr-815 (Fig. 1B). To test
which tyrosine residue was phosphorylated, synprint region
proteins with tyrosine-to-phenylalanine (Tyr3 Phe) mutations
were expressed and purified as His6-tagged fusion proteins and
phosphorylated by Src in vitro (Fig. 2A) (conversion to pheny-
lalanine removes the hydroxyl group on the phenyl ring of the
residue side chain required for phosphorylation). Mutation of
tyrosine 804 caused a 55% decrease compared with a positive
control containing both tyrosine residues (wild-type), whereas
mutation of the second tyrosine residue (Tyr-815) decreased
phosphorylation by 45% (Fig. 2B). In vitro phosphorylation
assays using [-32P]ATP confirmed these observations. In the
wild-type recombinant protein the stoichiometry of phosphoryl-
ation was 1.9 mol of phosphate/mol peptide, with a 57  9 and
43  10% decrease in phosphate incorporation in Phe-804 and
Phe-815 peptides, respectively (n  3). These results suggest
that both Tyr-804 and Tyr-815 can be phosphorylated. Neither
tyrosine residue falls within the canonical Asn-Pro-Xaa-Tyr(P)
motif commonly recognized by PTB domains (15, 16).
Synprint Peptides Slow the Desensitization Rate of GABA-
mediated Cav2.2 Channel Inhibition—We have shown previ-
ously that the endogenous RGS12 protein, and not other RGS
family members, controls the timing of desensitization of the
GABA-mediated, voltage-independent inhibition of calcium
current in embryonic DRG neurons (10). Thus, synthetic pep-
tides containing Tyr-804 and/or Tyr-815 (supplemental table I,
available in the on-line version of this paper) were tested in
electrophysiological assays to determine their ability to inter-
fere with the rate of desensitization of GABA-mediated inhibi-
tion of calcium current. Embryonic chick DRG neurons express
only one type of voltage-dependent calcium channel, the Cav2.2
(N-type, -conotoxin GVIA-sensitive) channel (17). Calcium
current as a function of time was monitored using whole-cell
FIG. 2. In vitro phosphorylation of phenylalanine-substituted mutant forms of the synprint region. A, recombinant, GST-tagged
channel loop proteins were expressed, phosphorylated by recombinant active Src, resolved by SDS-PAGE, and detected by immunoblotting with
a 4G10 anti-phosphotyrosine antibody. Asterisk indicates immunoblot detection of input Src kinase. As negative controls, recombinant proteins
were incubated in the kinase reaction mixture in the absence of kinase. Experiments were performed four independent times with similar results.
B, histogram showing quantitation of density of bands. Values represent the mean of four independent experiments  S.E. WT, wild-type; F804,
Phe-804; F815, Phe-815.
FIG. 1. The N terminus of RGS12
binds to the synprint region. A, a re-
combinant RGS12 N terminus binds to
the Src-phosphorylated synprint region
peptide in a protein overlay assay. Phos-
phorylated His6-tagged recombinant pro-
teins were resolved by SDS-PAGE and
transferred to a nitrocellulose membrane.
Membranes were incubated with 1 g/ml
recombinant GST fusion protein compris-
ing the N-terminal 440 amino acids of
RGS12. Data are representative of four
experiments. An anti-GST antibody
(1:2000) was used to detect binding. B,
sequence of loop II-III of a chick Cav2.2
channel. Tyrosine residues Tyr-804 and
Tyr-815 are indicated in red.
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electrophysiology to determine any agonist-independent effect
that the peptides might have on the basal calcium current.
Peptide concentrations from 1 nM to1 mM were introduced into
the cytosolic environment through the recording pipette. DRG
neurons were exposed to 100 M GABA (in the presence of 100
M bicuculline to block GABAA receptors), and both the mag-
nitude and the time course of the GABA-mediated voltage-
independent inhibition were determined. Under these experi-
mental conditions, the peptides did not cause a significant
change in the magnitude of voltage-independent inhibition;
GABA-induced voltage-independent inhibition was 34  8% in
control cells compared with 31  9% in the presence of peptide.
At 1 M, the 16-amino acid Tyr(P)-804-containing peptide
(supplemental table I) slowed the rate of desensitization by a
factor of 48, whereas the Tyr-804-containing peptide slowed the
rate of desensitization by a factor of 23 (peptides Tyr(P)-804
and Tyr-804 respectively; Fig. 3A). The mutation of Tyr-804 to
phenylalanine severely curtailed this effect on the desensitiza-
tion rate (peptide Phe-804 (F804); Fig. 3). Peptides containing
solely the second tyrosine motif (Tyr-815) had no significant
effect on the desensitization rate. Effects of Tyr-804-containing
peptides were observed at concentrations down to the nanomo-
lar range (1 nM; Fig. 3A). In contrast, even at high concentra-
tions the Tyr-815-containing peptides were without effect.
Although our previous data suggested that RGS12 interacts
with the calcium channel (10) in a phosphotyrosine-dependent
manner, both the Tyr(P)-804- and Tyr-804-containing peptides
altered the rate of desensitization of GABA-induced voltage-
independent inhibition of calcium current. We therefore tested
whether the Tyr-804-containing peptide could be phosphoryl-
ated within the cellular environment upon the activation of
GABAB receptors in DRG neurons. To answer this question, a
biotinylated and cell-permeant form of the Tyr-804 peptide was
introduced into DRG neurons, and then cells were exposed to
FIG. 3. Effect of synprint region peptides on the rate of desensitization of GABA-mediated, voltage-independent inhibition of a
Cav2.2 channel in chick DRG neurons. A, concentration dependence of the synprint peptide effect. Inward calcium current was evoked by
stepping from 80 to 0 mV for 50 ms. A protocol with 80 mV, a 20-ms prepulse, and a 5-ms interval prior to the test pulse was used to measure
the voltage-independent component of the inhibition. Peptides were introduced by passive diffusion through the recording pipette at the
concentrations indicated. Peak calcium current as a function of time was measured and plotted. The half-time to achieve maximal desensitization
was calculated as a function of peptide concentration. B, percentage of inhibition as a function of time. Each peptide listed was introduced at 1 M
into the DRG neurons, and the percentage of GABA-induced voltage-independent inhibition was measured as a function of time. C, tyrosine
phosphorylation of the Tyr-804-containing peptide inside DRG neurons. Neurons were incubated with the peptide and exposed to saline or baclofen
(to activate GABAB receptors) for 20 s. As a positive control, cells were incubated with Tyr(P)-804 peptide. Immunodetection was performed with
an anti-phosphotyrosine antibody (4G10; 1:500). Data are representative of four experiments. IB, immunoblot; Y804, Tyr-804; pY804, Tyr(P)-804;
Y815, Tyr-815; pY815, Tyr(P)-815; F804, Phe-804; F815, Phe-815.
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saline or an agonist prior to lysis. Cell lysates containing the
biotinylated peptide were spotted onto a streptavidin mem-
brane and detected by immunoblotting with an anti-phospho-
tyrosine antibody. The Tyr-804 peptide introduced into cells
exposed to baclofen exhibited a much higher degree of phos-
phorylation (Fig. 3C). This finding suggests that the Tyr-804
peptide becomes phosphorylated in the cellular environment of
the DRG neurons.
In time course electrophysiological experiments, cells con-
taining peptide Tyr-804 did not exhibit significant desensitiza-
tion after exposure to GABA for 200 s (Fig. 3B), whereas cells
containing other peptides or control internal solution exhibited
complete desensitization by 100 s. Results obtained in experi-
ments with the 27 amino acid peptides spanning Tyr-804 (sup-
plemental table I in the on-line version of this article) were the
same as the results obtained with the 16 amino acid peptides
spanning Tyr-804 (data not shown). These results suggest that,
whereas both Tyr-804 and Tyr-815 can be phosphorylated in
vitro (Fig. 2), only those peptides containing the Tyr-804-cen-
tered motif interfere with the rate of desensitization.
Mapping the Determinants of the RGS12/Synprint Motif
Interaction—SPR biosensor measurements were carried out
to test which phosphotyrosine residue-containing motif had
the potential to mediate association with RGS12 in vitro.
Initially, the ability of the recombinant GST-RGS12-(1–440)
fusion protein to bind biosensor surfaces pre-adsorbed with
Tyr(P)-804/Tyr-815 and Tyr-804/Tyr(P)-815 peptides was
tested. (Fig. 4A). As a positive control, a 20-amino acid bioti-
nylated peptide comprising the C terminus of the interleu-
kin-8 receptor CXCR2, which we have previously shown in-
teracts with the N-terminal RGS12 PDZ domain (18), was
used. The recombinant RGS12 N terminus was observed to
bind both the control CXCR2 peptide and the Tyr(P)-804/Tyr-
815 channel-loop peptide surfaces (Fig. 4A), whereas any
interaction with the Tyr-804/Tyr(P)-815 peptide was below
the detection limit of the SPR biosensor.
Fusion of the RGS12 N terminus with the 26-kDa GST
moiety allows for a higher signal-to-noise ratio in SPR meas-
urements, because the biosensor response is directly propor-
tional to the molecular mass of the analyte binding to the
biosensor (18). However, as mass transport and GST/GST
dimerization artifacts can complicate kinetic determinations
(19), independent SPR experiments were performed using low
density peptide surfaces and varying concentrations of the
FIG. 4. Binding of RGS12 to the tyrosine 804 motif in the SNARE-binding (synprint) site of the Cav2.2 channel. A, specific
phosphorylation-dependent binding of GST-RGS12 N terminus (amino acids 1–440) fusion protein to synprint motif peptides from the domain
II-III linker of Cav2.2 as assessed by SPR. Simultaneous SPR measurement of binding to biotinylated peptides from the chick synprint site
(Met-His-Asn-Phe-Arg-Asn-Ser-Cys-Glu-Ala-Leu-Tyr(P)-Asn-Glu-Leu-Asp-Pro-Glu-Glu-Arg-Val-Arg-Tyr-Ala-Thr-Thr-Leu (Tyr(P)-804/Tyr-815)
or Met-His-Asn-Phe-Arg-Asn-Ser-Cys-Glu-Ala-Leu-Tyr-Asn-Glu-Leu-Asp-Pro-Glu-Glu-Arg-Val-Arg-Tyr(P)-Ala-Thr-Thr-Leu (Tyr-804/Tyr(P)-815)
and to the C-terminal peptide from human interleukin-8 receptor B (CXCR2) after injection (time 0 s, flow rate 10 l/min) of 10 l of 3 M
GST-RGS12-(1–440) fusion protein at 25 °C. All SPR binding curves were subtracted from the response measured on an irrelevant peptide negative
control surface (Control). B, sample sensorgrams from a titration of a His6-RGS12-(1–440) protein injected over a Tyr(P)-804/Tyr-815 peptide
surface. Biotinylated Tyr(P)-804/Tyr-815 peptide was bound to the SPR biosensor surface, and the indicated concentrations of the His6-RGS12-
(1–440) recombinant protein (1 nM to 20 M) were serially injected as described under “Experimental Procedures.” The apparent dissociation
constant for the interaction between the His6-RGS12-(1–440) protein and the Tyr(P)-804/Tyr-815 peptide was 13.4  0.8 M, (mean  S.E. of four
independent sets of titrations). C, binding of endogenous RGS12 from chick DRG lysates to channel peptides. Biotinylated peptides from the chick
synprint site were bound to streptavidin-Sepharose beads and used to affinity-purify chick DRG lysates. Immunodetection of eluates was
performed using anti-RGS12 antibody (1:1000). D, values plotted in histogram showing quantitation of band density from immunoblots as in part
C represent the mean value from three independent experiments. F804, Phe-804; Y804, Tyr-804; pY804, Tyr(P)-804; Y815, Tyr-815.
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hexahistidine-tagged RGS12 N terminus protein to obtain an
apparent dissociation constant (KD) of 13.4  0.8 M for the
interaction with the Tyr(P)-804/Tyr-815 peptide (see represent-
ative dose-response curves in Fig. 4B).
We also tested the ability of Tyr-804- and Tyr-815-containing
peptides to interact with full-length, endogenous RGS12 by mi-
cro-affinity chromatography of chick DRG neuron lysates using
these biotinylated peptides bound to streptavidin resin. Although
RGS12 binding was detected in eluates from peptide columns
containing Tyr-804- and Tyr(P)-804-containing peptide columns,
no RGS12 was detected in eluates from peptide columns solely
containing Tyr-815- or Tyr(P)-815-centered motifs (Fig. 4C).
Collectively, our results suggest that a polypeptide span
surrounding Tyr-804 within the Cav2.2 channel synprint re-
gion is the binding site for RGS12. An alignment of this Cav2.2
channel region across different species indicates that this Tyr-
804 tyrosine residue has been conserved in multiple species
(Fig. 5). The surrounding residues are also conserved. To test
whether residues surrounding Tyr-804 contribute to the inter-
action with RGS12, peptides were designed with single residue
substitutions and tested for their ability to bind endogenous
RGS12 by streptavidin micro-affinity chromatography of chick
DRG neuron lysates. Most of the amino acid substitutions N-
and C-terminal to the Tyr-804 position decreased RGS12 bind-
ing to the background level seen for the Phe-804 negative
control (Fig. 6, a and b); three of the four positions at which
alanine substitutions did not abrogate RGS12 binding (Phe-
796, Asn-805, and Leu-807; Fig. 6a) are not conserved between
chick and mammalian Cav2.2 sequences (Fig. 5).
Because the RGS12 binding site is part of the SNARE-bind-
ing region of the calcium channel, we tested whether syntaxin
could bind to the synprint region peptides. By micro-affinity
chromatography, syntaxin was detected in eluates from Tyr-
804-containing peptide columns but not detected in eluates
from Tyr-815 or Tyr(P)-815 peptide columns (Fig. 6b and data
not shown). Unlike RGS12, the binding of syntaxin to Tyr-804-
containing peptides was not dependent on the phosphorylation
status of the tyrosine residue (Tyr-804 (Y804) versus Tyr(P)-
804 (pY804); Fig. 6c).
To test whether syntaxin and RGS12 compete for the same
binding region, Tyr-804 and Tyr(P)-804 peptide columns were
pre-incubated with the GST-RGS12-(1–440) fusion protein prior
to loading of the cell lysates. Tyr(P)-804 peptide columns bound
with recombinant RGS12 showed a decrease in syntaxin binding
(Fig. 6d). RGS12 was confirmed to be present in eluates from
Tyr(P)-804 peptide columns upon anti-GST immunoblotting (Fig.
6d). These results raise the possibility that syntaxin and RGS12
may compete for the same binding site in vivo.
DISCUSSION
RGS12 has the potential to serve as a signal transduction
“nexus” that modulates multiple signaling pathway compo-
nents by virtue of its multi-domain architecture including N-
terminal PDZ and PTB domains, a central RGS-box with Gi/
o-specific GTPase-accelerating activity, C-terminal Ras-
binding domains, and a GoLoco motif (13, 18, 20, 21). Our
previous studies of the involvement of RGS12 in modulating
presynaptic GABAB-receptor signaling in chick DRG neurons
suggest that RGS12, in binding to the calcium channel, modu-
lates channel activity directly in addition to its ability to accel-
erate G-subunit GTPase activity (10). Here we have mapped
the region of the calcium channel that interacts with RGS12 to
the SNARE-binding or synprint region (amino acids 726–985).
Introduction of a peptide that contains Tyr-804 and flanking
residues is sufficient to alter the rate of desensitization of the
GABA-mediated inhibition of calcium current.
Several proteins are known to bind to the synprint region,
an intracytosolic portion of the channel that has been exten-
sively studied as important for the regulation of both channel
activity and secretion (22). Binding of syntaxin to this chan-
nel region plays a role in voltage-dependent inhibition (23)
and is thought to stabilize the binding of G protein  sub-
units to the channel (24). Synaptotagmin also binds to the
channel in this region upon depolarization in a calcium-de-
pendent manner (25). We have shown here that RGS12 and
syntaxin are both capable of binding the Tyr-804-based pep-
tide motif; however, the RGS12 interaction appears to be
phosphorylation-dependent (see below), whereas the syn-
taxin interaction occurred irrespective of phosphorylation
status. The binding of RGS12 to the phosphorylated synprint
region prevents syntaxin binding. We are currently investi-
gating whether the binding of RGS12 to the calcium channel
synprint region can displace syntaxin protein from this site
and thus reverse the inhibition of the calcium channel.
FIG. 5. Sequence alignment of the RGS12-binding region of the calcium channel. A, sequence alignment of the RGS12-binding region
of Cav2.2 channels. Sequence alignment was performed using ClustalX. The positions of Tyr-804 and Tyr-815 have been highlighted with
arrowheads. GenBankTM accession numbers are as follows: mouse (Mus musculus), NP_031605; rat (Rattus norvegicus), NP_671482; rabbit,
Q05152; bovine (Bos taurus), NP_777057; and human (Homo sapiens), NP_000709. B, sequence comparison between the RGS12-binding regions
of Cav2.2 channel (bottom sequence, chick Cav2.2) with the same region in Cav2.1 channels from different species. Accession numbers are as follows:
mouse, AAC52940; rat, A41098; rabbit, P27884; human, AAB61613.
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The PTB domain was first identified in Shc (26, 27), a sig-
naling adaptor protein that mediates phosphotyrosine-depend-
ent interactions between growth factor receptor tyrosine ki-
nases and their downstream effectors (28). PTB domains were
first assumed to be strictly targeted to phosphotyrosine resi-
dues, as the prototypic PTB domains of Shc and IRS-1 were
found to recognize phosphotyrosine sites in the context of a
conserved sequence motif: Asn-Pro-Xaa-Tyr(P) (29, 30, 31).
However, as other PTB domains have been identified and their
binding sites characterized, it is clear that a PTB domain can
also have non-phosphorylated and non-Asn-Pro-Xaa-Tyr motif-
based polypeptide targets (15, 16). Here we have determined
that the RGS12 N terminus binds in a phosphotyrosine-de-
pendent manner to the synprint region polypeptide of the se-
quence Arg-Ala-Ser-Cys-Glu-Ala-Leu-Tyr(P)-Asn-Glu. This se-
quence, centered about Tyr-804, represents a novel target for
PTB domain interactions as it does not possess an Asn-Pro-
Xaa-pY motif and, moreover, mutagenesis of this sequence
suggests that at least one residue C-terminal of the phospho-
tyrosine (namely Glu-806) is required for the RGS12 interac-
tion. The interaction between recombinant RGS12-N-terminal
fusion proteins and the Tyr-804-centered synprint motif was
strictly dependent on tyrosine phosphorylation; however, both
electrophysiological measurements and cell lysate chromatog-
raphy suggested some activity also for the non-phosphorylated
Tyr-804-containing peptide. The simplest explanation for this
apparent dichotomy is phosphorylation of the synthetic Tyr-
804 peptide (e.g. Fig. 3C) by endogenous tyrosine kinase activ-
ity upon its addition to the DRG neurons (and lysates thereof),
which is under study.
Future experiments are necessary to determine whether the
tyrosine residue involved in the interaction between RGS12
and the Cav2.2 channel also plays a role in the onset of channel
modulation by a neurotransmitter. Point mutations of residues
Tyr-804 and Tyr-815 to phenylalanine in the context of the
full-length Cav2.2 channel will help to distinguish which resi-
due(s) are important for the onset of neurotransmitter-medi-
ated modulation and whether the phosphorylation of Tyr-804
causes inhibition of calcium influx prior to its interaction with
RGS12.
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